The in Silico Approach to Identify a Unique Plant-Derived Inhibitor Against E6 and E7 Oncogenic Proteins of High-Risk Human Papillomavirus 16 and 18

The in Silico Approach to Identify a Unique Plant-Derived Inhibitor Against E6 and E7 Oncogenic Proteins of High-Risk Human Papillomavirus 16 and 18

Background Globally, the human papillomavirus (HPV) remains the foremost cause of cancer mortality among women. There is a need to identify natural anti-cancerous compounds that can fight against life-threatening infections by HPV. Various kinds of natural plant-originated compounds have b...

Full description

Bibliographic Details
Main Authors:	Kumar, Jena, Sahoo, Nayak, Mohod, Daf, Varma
Format:	Article
Language:	English
Published:	Hamadan University of Medical Sciences 2016-05-01
Series:	Avicenna Journal of Medical Biochemistry
Online Access:	http://avicennajb.com/?page=article&article_id=33958

Similar Items

Docking to Explicate Interface between Plant-Originated Inhibitors and E6 Oncogenic Protein of Highly Threatening Human Papillomavirus 18
by: Satish Kumar, et al.
Published: (2015-06-01)

Molecular Docking Explains Atomic Interaction between Plant-originated Ligands and Oncogenic E7 Protein of High Risk Human Papillomavirus Type 16
by: Satish Kumar, et al.
Published: (2014-12-01)

Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis
by: Satish Kumar, et al.
Published: (2014-06-01)

hpvPDB: An Online Proteome Reserve for Human Papillomavirus
by: Satish Kumar, et al.
Published: (2013-12-01)

In silico Structural Prediction of E6 and E7 Proteins of Human Papillomavirus Strains by Comparative Modeling
by: Satish Kumar, et al.
Published: (2012-07-01)

Signification de la charge virale des papillomavirus humains oncogènes de type 16 et 18
by: Carcopino, Xavier
Published: (2011)

Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential
by: Tommasino Massimo, et al.
Published: (2011-06-01)

Association between oncogenic human papillomavirus type 16 and Killian polyp
by: Lucia Oton-Gonzalez, et al.
Published: (2021-01-01)

Preclinical investigation of DNA immunization with a rearranged human papillomavirus type 16 (HPV16) E7 oncogene
by: Gissmann L, et al.
Published: (2004-07-01)

In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants
by: Hugo Alberto Rodríguez-Ruiz, et al.
Published: (2019-08-01)

Human papillomavirus type 16 E6 and E7 oncogene expression in relation to host cell growth and differentiation
by: Choo, Chee-Keong
Published: (1994)

Analysis of pathways affected by the viral oncogenes in human papillomavirus 16-induced neoplastic progression
by: Untersperger, C. V.
Published: (2013)

An In silico approach to identify potential inhibitors against multiple drug targets of Mycobacterium tuberculosis
by: Satish Kumar, et al.
Published: (2019-01-01)

Ultrasensitive quantitation of human papillomavirus type 16 E6 oncogene sequences by nested real time PCR
by: López-Revilla Rubén, et al.
Published: (2010-05-01)

Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus
by: Maheswata Sahoo, et al.
Published: (2016-09-01)

Effects of metabolic inhibitors on the regulation of the expression of type 16 human papillomavirus genes and the c-myc oncogene in a cervical carcinoma cell line
by: Zhao, Pei-Ling, et al.
Published: (1990)

The endocytic trafficking pathway of oncogenic papillomaviruses
by: Snježana Mikuličić, et al.
Published: (2019-06-01)

Molecular characterization for oncogenic human papillomaviruses.
Published: (2006)

The Oncogenicity of Human Papillomavirus Type 58 E7 Variants
Published: (2016)

Sexual behavior and infection with cervical human papillomavirus types 16 and 18
by: Itarat Y, et al.
Published: (2019-08-01)

Regulation of tumour growth and apoptosis by oncogenes and papillomaviruses
by: Arends, Mark J.
Published: (1992)

Leukemia Inhibitory Factor Downregulates Human Papillomavirus-16 Oncogene Expression and Inhibits the Proliferation of Cervical Carcinoma Cells
by: Joseph M. Bay, et al.
Published: (2011-01-01)

Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
by: Ji Jia, et al.
Published: (2012-06-01)

Evaluation of human papillomavirus 16 and human papillomavirus 18 in saliva of chronic smokers in Malaysian population: An In vitro observational study
by: E V Soma Sekhar Goud, et al.
Published: (2017-01-01)

Cleroda-4(18),13-dien-15,16-olide as novel xanthine oxidase inhibitors: An integrated in silico and in vitro study.
by: Ha Thi Nguyen, et al.
Published: (2021-01-01)

Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly
by: Siaw Shi Boon, et al.
Published: (2019-12-01)

Footprinting of Inhibitor Interactions of In Silico Identified Inhibitors of Trypanothione Reductase of Leishmania Parasite
by: Santhosh K. Venkatesan, et al.
Published: (2012-01-01)

Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.
by: Minwuyelet Maru Temesgen, et al.
Published: (2021-01-01)

Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18
by: Yakelin Díaz-Tejeda, et al.
Published: (2021-07-01)

Studies on molecular mechanisms of transformation by human papillomavirus : the role of E6 and E5 oncogenes
by: Gu, Zhengming
Published: (1996)

IspE inhibitors identified by a combination of in silico and in vitro high-throughput screening.
by: Naomi Tidten-Luksch, et al.
Published: (2012-01-01)

Presence of Human Papillomavirus -16 and -18 Among Women with Breast Cancer in Isfahan Province
by: Pegah Hosseinpouri, et al.
Published: (2020-11-01)

Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer
by: Rossana de Araújo Catão Zampronha, et al.
Published: (2013-06-01)

A multiplexed human papillomavirus (HPV) 16 and 18 diagnostic for cervical cancer screening
by: Wong, Winnie S.
Published: (2019)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada
by: Kohli Michele, et al.
Published: (2012-10-01)

The inhibitory effect of small interference RNA of Human papillomavirus type 16 E6/E7 oncogenes on transforming phenotypes of TC-1 tumor cell line
by: Chao Chin Tu, et al.
Published: (2005)

The inhibitory effect of small interference RNA of Human papillomavirus type 16 E6/E7 oncogenes on transforming phenotypes of TC-1 tumor cell line
by: Chao Chin Tu, et al.
Published: (2005)

High Rate of Infection by Only Oncogenic Human Papillomavirus in Amerindians
by: Daniela Vargas-Robles, et al.
Published: (2018-05-01)

P16 Protein and Human Papillomavirus (HPV16, 18) Expressions in Oral Lichen Planus and Squamous Cell Carcinoma
by: Suhaib R Muhsin, et al.
Published: (2015-12-01)

Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women
by: Yan Tong, et al.
Published: (2020-07-01)